Core fucosylation of maternal milk N-glycan evokes B cell activation by selectively promoting the L-fucose metabolism of gut bifidobacterium spp. and lactobacillus spp

Article abstract of DOI:10.1128/mBio.00128-19

The maternal milk glycobiome is crucial for shaping the gut microbiota of infants. Although high core fucosylation catalyzed by fucosyltransferase 8 (Fut8) is a general feature of human milk glycoproteins, its role in the formation of a healthy microbiota has not been evaluated. In this study, we found that the core-fucosylated N-glycans in milk of Chinese mothers selectively promoted the colonization of specific gut microbial groups, such as Bifidobacterium spp. and Lactobacillus spp. in their breast-fed infants during lactation. Compared with Fut8+/+ (WT) mouse-fed neonates, the offspring fed by Fut8+/-maternal mice had a distinct gut microbial profile, which was featured by a significant reduction of Lactobacillus spp., Bacteroides spp., and Bifidobacterium spp. and increased abundance of members of the Lachnospiraceae NK4A136 group and Akkermansia spp. Moreover, these offspring mice showed a lower proportion of splenic CD19+ CD69+ B lymphocytes and attenuated humoral immune responses upon ovalbumin (OVA) immunization. In vitro studies demonstrated that the chemically synthesized core-fucosylated oligosaccharides possessed the ability to promote the growth of tested Bifidobacterium and Lactobacillus strains in minimal medium. The resulting L-fucose metabolites, lactate and 1,2-propanediol, could promote the activation of B cells via the B cell receptor (BCR)-mediated signaling pathway. IMPORTANCE This study provides novel evidence for the critical role of maternal milk protein glycosylation in shaping early-life gut microbiota and promoting B cell activation of neonates. The special core-fucosylated oligosaccharides might be promising prebiotics for the personalized nutrition of infants.

Full text of DOI:10.1128/mBio.00128-19

RESEARCH ARTICLE
Host-Microbe Biology
crossm
Core Fucosylation of Maternal Milk N-Glycan Evokes B Cell
Activation by Selectively Promoting the L-Fucose Metabolism
of Gut Bifidobacterium spp. and Lactobacillus spp.
Ming Li,a Yaqiang Bai,a Jiaorui Zhou,a Wei Huang,b Jingyu Yan,c Jia Tao,d Qingjie Fan,a Yang Liu,e Di Mei,e Qiulong Yan,a
Jieli Yuan,a Patrice Malard,f Zhongfu Wang,g Jianguo Gu,h Naoyuki Tanigchi,i Wenzhe Lia
aCollege of Basic Medical Science, Dalian Medical University, Dalian, China
bCAS Key Laboratory of Receptor Research, Chinese Academy of Sciences, Shanghai Institute of Materia Medica, Shanghai, China
cDalian Institute of Chemical Physics, Key Laboratory of Separation Science for Analytical Chemistry, Chinese Academy of Sciences, Dalian, China
dDepartment of Gynaecology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China
eClinical Laboratory of Huludao Center Hospital, Huludao, China
fBiostime Institute Nutrition & Care (BINC), Guangzhou, China
gEducational Ministry Key Laboratory of Resource Biology and Biotechnology in Western China, Life Science College, Northwest University, Xian, China
hDivision of Regulatory Glycobiology, Institute of Molecular Biomembrane and Glycobiology, Tohoku Medical and Pharmaceutical University, Sendai, Japan
iDepartment of Glyco-Oncology, Osaka International Cancer Institute, Osaka, Japan
ABSTRACT The maternal milk glycobiome is crucial for shaping the gut microbiota
of infants. Although high core fucosylation catalyzed by fucosyltransferase 8 (Fut8) is
a general feature of human milk glycoproteins, its role in the formation of a healthy
microbiota has not been evaluated. In this study, we found that the core-fucosylated
N-glycans in milk of Chinese mothers selectively promoted the colonization of spe-
cific gut microbial groups, such as Bifidobacterium spp. and Lactobacillus spp. in their
breast-fed infants during lactation. Compared with Fut8ϩ/ϩ (WT) mouse-fed neo-
nates, the offspring fed by Fut8ϩ/Ϫ maternal mice had a distinct gut microbial pro-
file, which was featured by a significant reduction of Lactobacillus spp., Bacteroides
spp., and Bifidobacterium spp. and increased abundance of members of the Lachno-
spiraceae NK4A136 group and Akkermansia spp. Moreover, these offspring mice
showed a lower proportion of splenic CD19ϩ CD69ϩ B lymphocytes and attenuated
humoral immune responses upon ovalbumin (OVA) immunization. In vitro studies
demonstrated that the chemically synthesized core-fucosylated oligosaccharides pos-
sessed the ability to promote the growth of tested Bifidobacterium and Lactobacillus
strains in minimal medium. The resulting L-fucose metabolites, lactate and 1,2-
propanediol, could promote the activation of B cells via the B cell receptor (BCR)-
mediated signaling pathway.
Citation Li M, Bai Y, Zhou J, Huang W, Yan J,
Tao J, Fan Q, Liu Y, Mei D, Yan Q, Yuan J, Malard
P, Wang Z, Gu J, Tanigchi N, Li W. 2019. Core
fucosylation of maternal milk N-glycan evokes
B cell activation by selectively promoting the
L-fucose metabolism of gut Bifidobacterium
spp. and Lactobacillus spp. mBio 10:e00128-19.
https://doi.org/10.1128/mBio.00128-19.
IMPORTANCE This study provides novel evidence for the critical role of maternal
milk protein glycosylation in shaping early-life gut microbiota and promoting B cell
activation of neonates. The special core-fucosylated oligosaccharides might be prom-
ising prebiotics for the personalized nutrition of infants.
Invited Editor Mariya Ivanova Petrova, KU
Leuven
Editor Xiaorong Lin, University of Georgia
Copyright © 2019 Li et al. This is an open-
access article distributed under the terms of
the Creative Commons Attribution 4.0
International license.
KEYWORDS B cells, Bifidobacterium, Lactobacillus, core fucosylation, infants,
milk N-glycan
Address correspondence to Ming Li,
vivianmarat@163.com, or Wenzhe Li,
liwenzhe@dlmedu.edu.cn.
he human milk glycobiome plays a pivotal role in shaping the gut microbiota of
L.M. and B.Y. contributed equally to this article.
T
infants (1, 2). In addition to providing nutrients and energy for newborns (3),
Received 30 January 2019
Accepted 26 February 2019
Published 2 April 2019
glycans in human milk can inhibit the adhesion of pathogens and promote intestinal
colonization and growth of probiotics (4, 5), resulting in a Bifidobacterium and Lacto-
bacillus enriched gut micro-ecosystem in breast-fed infants (6, 7). This early-life micro-
®
March/April 2019 Volume 10 Issue 2 e00128-19
mbio.asm.org 1

®
Li et al.
biome contributes significantly to the health outcomes of infants by regulating the
development of their immune system (8, 9). The neonatal innate immune system is
biased toward a TH2 phenotype, which is associated with allergy and autoimmune
diseases, and is biased against TH1 cells to avoid harmful proinflammatory responses
(10). Aberrant neonatal microbiota composition can elicit abnormal immune responses,
which is associated with diseases such as pediatric Crohn’s disease, asthma, and milk
allergy during childhood (9). In the newborn, short-chain fatty acids (SCFAs) are
produced through the bacterial fermentation of glycans that are present in breast milk
and SCFAs increase both mitochondrial energy production and glycolysis, which pro-
mote B cell differentiation and antibody (Ab) production (11).
The major glycosylated components in human milk include oligosaccharides
(HMOs), glycoproteins, and glycolipids (12). Recent advances in mass spectrometry
(MS)-based tools have provided a view of the HMOs’ structures that could be decorated
with either fucose and/or sialic acid moieties (13, 14). The fucosylated HMOs were
found to function as prebiotics for infant-favorable Bifidobacterium strains and vary
significantly between mothers of different secretory statuses, which is determined by
single nucleotide polymorphisms (SNPs) of the maternal fucosyltransferase 2 (Fut2)
gene (15). In contrast, despite the high abundance of glycoproteins in milk (approxi-
mately 8 g/liter) (12, 13), harboring both N-linked and O-linked glycan moieties, few
studies have focused on the regulatory role of milk protein glycosylation on gut
microbial structure of neonates, even though bacterium-derived glycohydrolases (GHs)
have long been regarded as effective enzymes to release protein-bound glycans (16,
17). Once released from the glycoproteins, these glycans can also be considered
selective growth substrates for infant-associated gut microbes (18, 19).
Fucosylation is a common type of posttranslational protein modification. Notably,
high fucosylation is a general feature of human milk (20), with 75% fucosylation
distribution in N-glycans compared with bovine milk (31%). The fucosylation process
can be modified by several fucosyltransferases (Fut proteins), including Fut2, Fut3, and
Fut8, which transform the fucose residues by ␣1,2/3, ␣1,3/4, or ␣1,6 linkages, respec-
tively (21). For vertebrate protein N-glycans, the main fucosylation process is catalyzed
by fucosyltransferase 8 (Fut8), which transfers L-fucose to N-acetylglucosamine (GlcNAc)
adjacent to the asparagine (N) residue by an ␣1,6 linkage (Fig. 1A) (22). Fut8-mediated
core fucosylation is an important posttranslational process in mammals (23–25). Indeed,
the most important and abundant milk proteins, including lactoferrin (LF) and immu-
noglobulins (IgG, IgM, and secretory IgA [sIgA]) are heavily core fucosylated (21, 26–28).
It was found that SNPs in the Fut8 gene among human populations were closely
associated with the fucosylation patterns of N-glycans (29). In addition, our previous
studies indicated that Fut8 gene knockout (Fut8Ϫ/Ϫ) mice showed growth retardation
and abnormal development of immune system (27, 29–31). We therefore asked
whether variations in milk protein core fucosylation levels caused by Fut8 gene SNP in
lactating mothers can affect the gut microbiome of breast-fed infants.
In this study, we first evaluated the correlation between the milk protein core
fucosylation levels of Chinese mothers and the gut microbial patterns of their breast-
fed infants during lactation. In addition, to investigate the subsequent effects of milk
N-glycan core fucosylation status on offspring, we compared the gut microbiota, as well
as the immune development of Fut8ϩ/ϩ mouse neonates fed by Fut8ϩ/Ϫ or Fut8ϩ/ϩ
maternal mice. Our study provides novel evidence for the critical role of milk N-glycan
in shaping early-life gut microbiota and promoting immune responses.
RESULTS
Core fucosylation of milk N-glycan varies significantly among individual moth-
ers. To investigate the core fucosylation pattern of human milk protein, we isolated
whey proteins from the milk samples from 56 Chinese mothers collected at days 6, 42,
and 120 postpartum (Table 1). By mass spectrometry, we first profiled the entire milk
N-glycan repertoire of Chinese mothers. More than 20 major N-glycan compositions
were observed in the milk samples (Fig. 1B). In accordance with previous research (32),
March/April 2019 Volume 10 Issue 2 e00128-19
mbio.asm.org
2

®
Core Fucosylation of Milk N-Glycan Evokes B Cell
FIG 1 Core fucosylation level of milk N-glycan is associated with maternal Fut8 gene status. (A) Sketch map of how Fut8 catalyzes the transfer of an L-fucose
residue from GDP-fucose to the innermost N-acetylglucosamine (GlcNAc) on the asparagine (Asn) residue of N-glycans via ␣1,6 linkage. (B) Mass spectrometry
of N-glycan structures of breast milk protein derived from Chinese mothers. Red triangles, fucose; blue squares, GlcNAc; green circles, mannose; yellow circles,
galactose; purple diamonds, NeuAc. (C) The rs10483776 SNP (A¡G) allele of the maternal Fut8 gene detected by DNA sequencing. (D) Fut8 enzyme activities
in the cells of breast milk detected by high-performance liquid chromatography (HPLC). Activity was expressed as picomoles of GDP-fucose transferred to the
acceptor per hour per milligram of protein. S is the peptide substrate, and P is the product of fucosylation. (E) Densitometric analysis of the bands of AOL in
each breast milk sample between the G and A groups at days 6 and 42 postpartum. Data are shown as mean Ϯ SEM (*, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001).
TABLE 1 Subject characteristics
Value fora:
Characteristic
Group G
Group A
Fut8 gene SNP at rs10483776
G (n ϭ 15)
A (n ϭ 28)
No. of samples from milk/infants’ feces
Day 6
Day 42
Day 120
15/11
14/11
7/7
28/13
19/12
13/11
Maternal age (yr)
28.50 Ϯ 0.487
25.48 Ϯ 4.875
38.86 Ϯ 1.025
53.33 (8/15)
27.85 Ϯ 0.487
25.90 Ϯ 5.625
38.05 Ϯ 0.928
50.00 (14/28)
Maternal BMI (kg/m2)b
Gestation duration (wk)
Gender of infants, % male (no. male/total)
Body wt of infants (kg)
Birth
Day 6
Day 42
Day 120
3.106 Ϯ 0.146
3.425 Ϯ 0.175
5.014 Ϯ 0.168
7.246 Ϯ 0.388
3.098 Ϯ 0.087
3.405 Ϯ 0.315
5.003 Ϯ 0.575
7.180 Ϯ 0.650
aValues are means Ϯ standard deviations (SD), except for numbers or percentages of samples. The total
number of values was 56. The total number of samples from secretor mothers was 43. The mode of
delivery was vaginal for 100% of the mothers, and the mode of feeding was breastfeeding for 100% of the
infants. Maternal secretor status was found to affect the gut microbiota composition of breast-fed infants.
We examined the maternal secretor status and eliminated samples of nonsecretor mothers (n ϭ 13) and
their infants (Table S1). The remaining secretors were grouped into the G and A groups according to their
Fut8 gene status (SNP at rs10483776).
bBMI, body mass index.
March/April 2019 Volume 10 Issue 2 e00128-19
mbio.asm.org 3

®
Li et al.
the N-glycans in these milk samples were heavily core fucosylated. The high core
fucosylation level of milk protein was further demonstrated by lectin blotting with
Aspergillus oryzae lectin (AOL), which preferentially recognizes core fucosylation on
N-glycans (33). Major milk glycoproteins such as LF, IgA, and IgG are all highly core
fucosylated (see Fig. S1A in the supplemental material). Interestingly, we found that the
core fucosylation levels of milk proteins varied significantly among individual mothers
(Fig. S1B). A previous study showed that the plasma fucosylation levels were highly
correlated with SNPs in the human Fut8 gene (34), in which a G/A polymorphism of
rs10483776 on chromosome 14 significantly affected plasma fucosylation levels of
females. By DNA sequencing, the A¡G polymorphism of rs10483776 was found in 15
of the 56 Chinese mothers providing samples (Fig. 1C; see Table S1 in the supplemental
material). Moreover, the Fut8 enzyme activity of the cells in milk samples was increased
in mothers within the “G” group (Fig. 1D). Importantly, the core fucosylation level of
milk proteins from G group mothers was markedly higher than that of the “A” group
mothers during different lactation stages (day 6, P ϭ 0.0004; day 42, P ϭ 0.0236; and
day 120, P ϭ 0.0027), while the protein concentrations of milk samples within the two
groups were similar (Fig. 1E; see Fig. S2 in the supplemental material [all P values are
Ͼ0.05]).
Core fucosylation level of maternal milk N-glycan affects the gut microbiome
of infants. Because the core fucosylation levels of milk N-glycan were significantly
different among individual mothers, we investigated whether this variation affects the
gut microbiota composition of their breast-fed infants. By high-throughout sequencing
of gut bacterial genes, we analyzed the intestinal microbiome of infants at days 6, 42,
and 120 after birth (Table 1). Because maternal Fut2 gene status was found to affect
HMO abundance and the gut microbiota composition of breast-fed infants, we exam-
ined the maternal secretor status and eliminated samples of nonsecretor mothers and
their infants (Table 1; Table S1). Of the remaining samples, a comparison of the total
and major HMOs between the A and G groups resulted in no significant difference as
detected by a newly developed liquid chromatography-mass spectrometry (LC-MS)
system (Fig. S3 [details in Materials and Methods]).
The 16S rRNA sequencing of fecal samples from 6-day-old infants obtained a total
of 1,968,299 high-quality filtered reads, which were assembled into 82,012 effective
tags per infant. After systematic analysis, we found that the alpha diversity of infants’
gut microbiota reflected by Chao1 and the Shannon index showed no significant
difference between the corresponding groups (Table S2 [all P values are Ͼ0.05). The
dominant bacterial phyla in the gut of 6-day-old infants fed by G group mothers were
Actinobacteria (47.89% Ϯ 15.45%) and Proteobacteria (31.57% Ϯ 16.71%), which consti-
tuted more than 79.46% of the total bacteria (Fig. 2A). In contrast, the gut microbiota
of infants fed by A group mothers was dominated by Proteobacteria (46.37% Ϯ
14.20%) and Firmicutes (33.73% Ϯ 15.43%), with a lower abundance of Actinobacteria
(14.55% Ϯ 6.78%; P ϭ 0.0438 compared with G group). By day 42, the relative abun-
dances of Actinobacteria (37.56% Ϯ 9.87%) and Proteobacteria (27.20% Ϯ 7.21%)
still occupied the major proportion of total gut microbiota in infants fed by high-
G-group mothers, and the average abundance of Bacteriodetes in these infants was
20.86% Ϯ 8.22%. In contrast, the abundances of Actinobacteria (25.27% Ϯ 3.15%) and
Bacteriodetes (12.50% Ϯ 7.29%) were much lower in gut of infants fed by A group
mothers (P ϭ 0.0285 and P ϭ 0.0327). By day 120, the relative abundance of Firmicutes
had become the major phylum in infants of both groups (47.20% Ϯ 8.51% in the G
group and 42.89% Ϯ 6.73% in the A group; P Ͼ 0.05), the abundance of Actinobacteria
in the G group is 21.30% Ϯ 3.43%, which was no longer higher than that in the A group
(25.35% Ϯ 5.57%; P Ͼ 0.05).
At the genus level (Fig. 2B), 6-day-old infants fed by mothers with higher core-
fucosylated milk (G group) harbored a higher abundance of Bifidobacterium
(46.68% Ϯ 5.24%), whereas the relative abundance of Bifidobacterium (14.29% Ϯ 3.61%)
was significantly lower (P ϭ 0.0028) in the gut of A group infants. By days 42 and 120,
Bifidobacterium was still more abundant in infants fed by G group mothers than in those fed
March/April 2019 Volume 10 Issue 2 e00128-19
mbio.asm.org
4

®
Core Fucosylation of Milk N-Glycan Evokes B Cell
FIG 2 Core fucosylation of milk N-glycan regulates the gut microbiome of infants. (A) The fecal microbiota profiles of infants fed by mothers with high (G
group)- or low (A group)-core-fucosylated milk N-glycan at the phylum level based on 16S rRNA gene sequencing. (B) The fecal microbiota profiles of infants
at genus level. (C) Characteristics of infant gut microbiota at days 6, 42, and 120 postpartum, illustrated by principal-coordinate analysis (PCoA) clustering
analyses. Data from individuals (points) were clustered, and the centers of gravity were computed for each class. (D) The linear discriminant analysis effect size
(LefSe) was adopted to identify the bacterial groups that showed significant differences in abundance between the high (G) and low (A) groups at day 6
postpartum. (E) Use of the Kyoto Encyclopedia of Genes and Genomes (KEGG) to evaluate the gut microbial functions between the high and low groups at
day 42 postpartum. In order to screen the marker genes with significant differences between groups, the difference function between different groups was first
detected by rank sum test and the dimension reduction was evaluated by LDA (linear discriminant analysis). The length of the histogram represents the
influence of the difference function. (F) The Carbohydrate-Active enZYmes Database (CAZy) was used to evaluate the gut microbial functions of infants within
the high and low groups at day 42 postpartum. GHs, glycoside hydrolases; GTs, glycosyl transferases; PLs, polysaccharide lyases; CEs, carbohydrate esterases;
AAs, auxiliary activities; CBMs, carbohydrate-binding modules.
by A group mothers (day 42, 31.46% Ϯ 3.47% versus 23.97% Ϯ 2.96%, P ϭ 0.0462; day 120,
30.59% Ϯ 3.65% versus 25.36% Ϯ 5.83%, P Ͼ 0.05). In contrast, the abundance of Lactoba-
cillus spp. in gut of infants was much lower compared than that of Bifidobacterium spp.
during early lactation (day 6 to day 42); Lactobacillus occupied no more than 1.00% of the
total bacteria. However, the proportion of this genus was largely increased by day 120, and
we observed a significant difference between the G and A groups (43.19% Ϯ 7.89% versus
March/April 2019 Volume 10 Issue 2 e00128-19
mbio.asm.org 5

®
Li et al.
14.21% Ϯ 3.71%; P ϭ 0.0256). The major Bifidobacterium and Lactobacillus spp. detected in
gut of the infants include Bifidobacterium pseudocatenulatum, Bifidobacterium bifidum,
Bifidobacterium breve, Lactobacillus gasseri, Lactobacillus mucosae, Lactobacillus casei, and
Lactobacillus fermentum, etc.: the relative abundances of most of these species were much
higher in G group infants than those in A group infants as detected at days 6, 42, and 120
postbirth (see Fig. S4 in the supplemental material).
By using principal-coordinate analysis (PCoA), we decomposed all the OTU data into
two main factors that explained 67.72% (day 6), 70.41% (day 42), and 37.71% (day 120)
of the variance (Fig. 2C). All the fecal samples of infants mainly clustered into the two
groups were highly correlated with the maternal Fut8 gene phenotype (day 6, P ϭ
0.0026, day 42, P ϭ 0.04937, and day 120, P ϭ 0.0385, as analyzed by weighted UniFrac
t test). The linear discriminant analysis (LDA) effect size (LEfSe) was further adopted to
identify the bacterial groups that showed significant differences in abundance between
groups. As shown in Fig. 2D, the phylum of Actinobacteria in infants fed by G group
mothers at day 6 was significantly (LDA score ϭ 5.00) more abundant than that for the
A group, which mainly contained B. pseudocatenulatum (LDA score ϭ 4.48). The genus
Ammoniphilus and species of L. casei were also significantly more abundant in infants within
the G group (LDA scores ϭ 4.02 and 4.32, respectively). In contrast, the key phylo-
types (significantly more abundant microbial groups) detected in infants fed by
mothers with low-core-fucosylated breast milk (A group) was the class of Clostridia
(LDA score ϭ 4.49), which mainly contained a rich abundance of Tyzzerella (LDA
score ϭ 4.00), a genus belonging to the family of Lachnospiraceae under the order of
Clostridiales. In addition, Corynebacterium tuberculostearicum, part of the normal skin
flora (35), was also abundant in this group (LDA score ϭ 4.11). Ammoniphilus and
Corynebacterium are rarely found in human gut; thus, our observation may due to
environmental and ethnic effects on our study cohort. No key phylotypes were de-
tected between infants of the two groups by day 42. However, as the lactation duration
increased, the Lactobacillus spp. (LDA score ϭ 4.95) became new biomarkers in the gut
of infants fed by mothers with high-core-fucosylated milk, and the genera Pseudomonas
(LDA score ϭ 4.00) and undefined Clostridiales (LDA score ϭ 4.47) were significantly
more abundant in infants fed by mothers with low-core-fucosylated milk N-glycans.
Using the Kyoto Encyclopedia of Genes and Genomes (KEGG) and the Carbohydrate-
Active enZYmes Database (CAZy), we further evaluated the gut microbial functions
between the groups to identify the major enzymes/pathways involved in the metab-
olism of fucosylated milk N-glycans. Fifteen KEGG modules were preferentially enriched
in feces of infants collected by day 42 postbirth (Fig. 2E; n ϭ 11 in the G group, and
n ϭ 12 in the A group): in the G group, 12 were identified as ␤-galactosidase (K12308),
putative ABC transport system permease protein (K10119), long-chain acyl coenzyme A
(acyl-CoA) synthetase (K01897), implicating the upregulation of glycan hydrolysis,
transportation, and biosynthesis of energy in gut microbes. The CAZy database analysis
revealed that infants fed by G group mothers had enriched genes associated with
glycoside hydrolases (GHs) and glycosyl transferases (GTs) (Fig. 2F).
Fut8؉/؊ maternal mouse-fed neonates have distinct gut microbiota. To exam-
ine the effects of milk N-glycan core fucosylation on offspring gut microbiota and
health development, female mice with a heterozygous Fut8 gene (Fut8ϩ/Ϫ) were
adopted as maternal models with low-core-fucosylated milk N-glycan compared with
wild-type (Fut8ϩ/ϩ) mice, and their effects on Fut8ϩ/ϩ offspring were evaluated
(Fig. 3A). As expected, the core fucosylation level of N-glycans in the breast milk of
Fut8ϩ/Ϫ mice was reduced compared with that in Fut8ϩ/ϩ mice (Fig. 3B). The activity
of Fut8 in Fut8ϩ/Ϫ mice was about half that of Fut8ϩ/ϩ mice (Fig. 3C). After lactation for
3 weeks, the body weight of offspring mice fed by Fut8ϩ/Ϫ mice was similar to those
of offspring fed by Fut8ϩ/ϩ mice (Fig. 3D; P Ͼ 0.05, n ϭ 3). However, alterations in the
gut microbiota of the offspring fed by Fut8ϩ/Ϫ mice were observed. As shown in Fig. 3E,
the PCoA revealed a distinct clustering of microbiota composition between Fut8ϩ/ϩ and
Fut8ϩ/Ϫ mouse-fed offspring, suggesting a significant difference in their beta diversity (P ϭ
March/April 2019 Volume 10 Issue 2 e00128-19
mbio.asm.org
6

®
Core Fucosylation of Milk N-Glycan Evokes B Cell
FIG 3 Fut8ϩ/Ϫ maternal mouse-fed neonates have distinct gut microbiota compared with the Fut8ϩ/ϩ maternal mouse-fed neonates. (A) Experimental design.
Female mice with a heterozygous Fut8 gene (Fut8ϩ/Ϫ) were adopted as maternal models with low-core-fucosylated milk N-glycan compared with wild-type mice
(Fut8ϩ/ϩ), and their effects on Fut8ϩ/ϩ offspring were evaluated. (B) The breast milk proteins of mice were analyzed by SDS-PAGE and AOL blotting (1:8,000).
The Coomassie brilliant blue (CBB) staining of gels shows comparable amounts of whole-protein lysates in each sample. (C) Fut8 enzyme activities in the cells
of mammary gland from maternal mice by detected by HPLC. (D) Photos of the neonatal mice fed by Fut8ϩ/ϩ and Fut8ϩ/Ϫ mothers after 3 weeks of lactation,
and their body weights during lactation were compared. Data are reported as mean Ϯ SEM. n.s., no significant differences between groups were detected. (E)
The fecal microbiota profiles of Fut8ϩ/ϩ and Fut8ϩ/Ϫ maternal mouse-fed offspring at the phylum level based on 16S rRNA gene sequencing. (F) The PCoA
revealed distinct clustering of microbiota composition between Fut8ϩ/ϩ and Fut8ϩ/Ϫ maternal mouse-fed offspring. (G) The relative abundance of fecal
microbial groups of Fut8ϩ/ϩ and Fut8ϩ/Ϫ maternal mouse-fed offspring at the genus level.
0.0363, weighted UniFrac t test). The major bacterial phyla in offspring fed by Fut8ϩ/ϩ mice
were Bacteroidetes (63.13% Ϯ 5.85%), Firmicutes (33.21% Ϯ 5.32%), and Proteobacteria
(3.16% Ϯ 0.38%) (Fig. 3F). Notably, the Bacteroidetes group (especially Bacteroides acidifa-
ciens), which can ferment a wide range of sugar derivatives (36), was significantly affected
by the reduction of core-fucosylated N-glycan in the milk of Fut8ϩ/Ϫ mice (33.30% Ϯ 6.89%,
March/April 2019 Volume 10 Issue 2 e00128-19
mbio.asm.org 7

®
Li et al.
P ϭ 0.0475, compared with Fut8ϩ/ϩ mouse-fed neonates). Conversely, Firmicutes
(53.80% Ϯ 9.65%) and Verrucomicrobia (9.95% Ϯ 0.85%) were more abundant in the gut of
Fut8ϩ/Ϫ mouse-fed neonates (P ϭ 0.0221 and P ϭ 0.019, respectively). At the genus level,
the gut of neonates fed by Fut8ϩ/Ϫ mice was characterized by reduction of Bacteroides
(29.02% Ϯ 1.20% versus 2.75% Ϯ 0.08%; P ϭ 0.0360) and Lactobacillus (12.25% Ϯ 1.21%
versus 4.52% Ϯ 0.49%; P ϭ 0.0389) and increased abundance of members of the Lachno-
spiraceae NK4A136 group (4.61% Ϯ 0.48% versus 24.63% Ϯ 1.59%; P ϭ 0.0152) and Akker-
mansia spp. (0.03% Ϯ 0.00% versus 9.94% Ϯ 0.85%; P ϭ 0.0179), compared with Fut8ϩ/ϩ
mouse-fed neonates (Fig. 3G). Bifidobacteria are not autochthonous to the mouse gut, but
we still detected a small portion of them in mice of our study: the abundance of Bifido-
bacterium was found significantly lower in the neonates fed by Fut8ϩ/Ϫ mice than in those
fed by Fut8ϩ/ϩ mice (0.22% Ϯ 0.08% versus 0.02% Ϯ 0.01%; P ϭ 0.0099) (see Fig. S5 in the
supplemental material).
Fut8؉/؊ maternal mouse-fed neonates showed lower proportion of splenic
CD19؉ CD69؉ B lymphocytes and attenuated humoral immune response. Since
aberrant neonatal microbiota composition can elicit abnormal immune responses, we
further investigated the population of lymphocytes in spleen and thymus of offspring
mice. A significantly reduction in the total lymphocyte numbers in the spleen and
thymus of Fut8ϩ/Ϫ mouse-fed offspring were detected compared with those fed by
Fut8ϩ/ϩ mice (see Fig. S6 in the supplemental material [P ϭ 0.0076 and P ϭ 0.0009;
n ϭ 3]). Flow cytometry analysis revealed that the frequencies of B cells (CD19ϩ) and
macrophages (F4/80ϩ) were significantly reduced in Fut8ϩ/Ϫ mouse-fed offspring (P ϭ
0.0454 and P ϭ 0.0233; n ϭ 3), whereas those of TER119ϩ cells were increased (Fig. 4A
[P ϭ 0.0439; n ϭ 3]), The proportions of CD4ϩ T cells, CD8ϩ T cells, Gr-1ϩ cells, CD11Cϩ
cells, and NK cells (DX5ϩ) in these mice were comparable with control. As B cells play
important roles in humoral immunity by secreting antibodies, we therefore immunized
the neonates after breastfeeding for 3 weeks by Fut8ϩ/Ϫ or Fut8ϩ/ϩ mice (Fig. 4B) and
compared the serum IgG levels of them to each other. As shown in Fig. 4C, significantly
lower level of serum IgG in Fut8ϩ/Ϫ mouse-fed offspring (P ϭ 0.0421; n ϭ 3) was found
compared with Fut8ϩ/ϩ mouse-fed offspring post-ovalbumin (OVA) immunization,
which was in accordance with the lower proportion of B cells observed (Fig. 4D [P ϭ
0.0168; n ϭ 3]). However, when we treated the offspring mice with a minimally effective
dose of mixed antibiotics (mixAbx), which effectively decreases gut microbiota without
affecting B cell survival in vitro (Fig. 4E) (11), no difference in splenic B cell proportions
was observed between Fut8ϩ/ϩ and Fut8ϩ/Ϫ mouse-fed offspring (Fig. 4F [P Ͼ 0.05]).
These results suggested that the regulatory role of core-fucosylated milk N-glycan on
humoral immunity of neonates was gut microbiota dependent.
Metabolites of L-fucose by Lactobacillus and Bifidobacterium spp. evoked B cell
activation in vitro. Previous studies (37, 38) showed that the metabolism of L-fucose in
Bifidobacterium and Lactobacillus spp. harboring a L-fucose operon resulted in the
production of 1,2-propanediol and L-lactate. Indeed, when we cultured B. pseudo-
catenulatum CGMCC1.5001, L. casei ATCC 334, and L. gasseri ATCC 33323 strains with
L-fucose, we detected the growth of these strains and the production of 1,2-
propanediol and lactate (Fig. 5A). Next, we asked whether the metabolites of L-fucose
can exert effects on B lymphocytes in the Peyer’s patches (PPs) of mice. To test this, we
isolated total lymphocytes from the PPs of mice and incubated them with 1,2-
propanediol and lactate. The results showed that the frequencies of B cells (CD19ϩ) and
activated B cells (CD69ϩ CD19ϩ) (39) in PPs were markedly increased following
stimulation with these metabolites (Fig. 5B [all P values are Ͻ0.0001; n ϭ 3]).
The recognition of antigen by the B cell receptor (BCR) complex on the surface of B
cells triggers signaling cascades via spleen tyrosine kinase (Syk) that ultimately lead to
B cell activation and development (40). To further elucidate the role of L-fucose
metabolites in B cell activation, we incubated 1,2-propanediol and lactate with 3-83 B
cells (expressing IgG2a-BCR recognizing p31), and assessed the phosphorylation level
of Syk. Compared with 3-83 cells, the phosphorylation levels of Syk, as can be induced
by p31, were upregulated upon treatment with L. gasseri supernatant and cell lysates
March/April 2019 Volume 10 Issue 2 e00128-19
mbio.asm.org
8

®
Core Fucosylation of Milk N-Glycan Evokes B Cell
FIG 4 Fut8ϩ/Ϫ maternal mouse-fed neonates showed a lower proportion of splenic CD19ϩ CD69ϩ B lymphocytes and attenuated humoral immune response.
(A) Flow cytometry analysis of the proportion of spleen cells in Fut8ϩ/ϩ and Fut8ϩ/Ϫ maternal mouse-fed offspring. Numbers indicate the percentage of the
indicated cell groups in total spleen cells. Ten thousand events were acquired for each analysis. Data are representative of three independent experiments and
are shown as mean Ϯ SEM (*, P Ͻ 0.05). (B) Experimental design. Fut8ϩ/ϩ and Fut8ϩ/Ϫ maternal mouse-fed offspring were immunized by abdominal cavity
injection with 50 ␮g of OVA mixed with an equal volume of complete Freund’s adjuvant (CFA). Two weeks later, mice were immunized with 50 ␮g of OVA by
subcutaneous injection. Mice sera were collected before and 14 days post-OVA immunization. (C) Comparison of the levels of serum IgG in Fut8ϩ/ϩ and Fut8ϩ/Ϫ
maternal mouse-fed offspring after immunization. The concentrations of IgG in the sera of mice (n ϭ 3/group) were measured by enzyme-linked immunosor-
bent assay (ELISA) using mouse MAb isotyping reagents. Data are shown as mean Ϯ SEM (n ϭ 3; *, P Ͻ 0.05). (D) Flow cytometry analysis of the CD3ϩ and CD19ϩ
cell proportions in spleen of Fut8ϩ/ϩ and Fut8ϩ/Ϫ maternal mouse-fed offspring after immunization. Data are shown as mean Ϯ SEM (n ϭ 3; *, P Ͻ 0.05). (E)
Experimental design. Fut8ϩ/ϩ and Fut8ϩ/Ϫ maternal mouse-fed offspring were orally administered with a minimally effective dose of antibiotics (mixAbx:
ampicillin, neomycin, and metronidazole at 40 mg/liter and vancomycin at 20 mg/liter) from the 10th day to the 21st day after birth. (F) Flow cytometry analysis
of the CD3ϩ and CD19ϩ cell proportions in spleen of Fut8ϩ/ϩ and Fut8ϩ/Ϫ maternal mouse-fed offspring after immunization. Data are shown as mean Ϯ SEM
(n ϭ 3). n.s., no significant differences were detected between groups.
(Fig. 5C [all P values are Ͻ0.05]). Consistent with the change in B cell activation among
PP cells, the L-fucose metabolites of L. gasseri enhanced the phosphorylation of Syk at
a dose of 10 ␮g/ml. However, the incubation of 3-83 B cells with 1,2-propanediol or
lactate did not result in the increased phosphorylation of the p42 and p44 isoforms of
mitogen-activated protein kinase (MAPK) (Erk1 and Erk2, respectively) (Fig. 5D). This
March/April 2019 Volume 10 Issue 2 e00128-19
mbio.asm.org 9

®
Li et al.
FIG 5 Metabolites of L-fucose by Lactobacillus and Bifidobacterium evoke B cell activation in vitro. (A) The bacterial strains were first cultured in enrichment
media (Table S3), and to observe the effects of L-fucose on their growth, they were inoculated in media without glucose and replaced by L-fucose at the
indicated final concentrations. The strains cultured in sugar-free media were used as controls. The production of 1,2-propanediol and lactate in culture broth
was measured by ELISA. Data are shown as mean Ϯ SEM (n ϭ 3). *, P Ͻ 0.05 compared with the control group. (B) Flow cytometry analysis of the proportion
of B cells (CD19ϩ CD69ϩ) activated by 1,2-propanediol and lactate in Peyer’s patches (PPs) of mice. (C) The phosphorylation level of Syk in 3-83 B cells was
assessed upon treatment of L-fucose metabolites. The blots were probed by anti-pSyk and anti-Syk Abs. Shown is densitometric analysis of the bands of pSyk
normalized with Syk. Data are shown as mean Ϯ SEM (n ϭ 3). *, P Ͻ 0.05, and **, P Ͻ 0.01, compared with the control group. (D) The phosphorylation level
of p42 and p44 isoforms of MAPK (Erk1 and Erk2, respectively) in 3-83 B cells was assessed. Shown is densitometric analysis of the bands of p42 and p44 MAPK
normalized with MAPK. Data are shown as mean Ϯ SEM (n ϭ 3). n.s., not significant. (E) The interactions of BCR with 1,2-propanediol and lactate were analyzed
by Biacore. Analytic concentrations (from top to bottom) are 12.3, 4.1, 1.37, and 0.45 ␮M.
suggests that these metabolites activate B cells through BCR signaling pathway, but not
MAPK pathway. Furthermore, we adopted a new Biacore strategy to analyze the
molecular interactions between L-fucose metabolites and BCR. 1,2-Propanediol and
lactate were found to interact directly with BCR protein at a concentration range of 1.37
to ϳ12.3 ␮M (Fig. 5E), which further supported our hypothesis that the L-fucose
metabolites of Bifidobacterium and Lactobacillus spp. induce B cell proliferation and
activation through the BCR-mediated signaling pathway.
March/April 2019 Volume 10 Issue 2 e00128-19
mbio.asm.org 10

®
Core Fucosylation of Milk N-Glycan Evokes B Cell
FIG 6 Core-fucosylated oligosaccharides promote the growth of tested Bifidobacterium and Lactobacillus strains (A) The basic fucosyl structure on milk
N-glycan: Fuc-␣1,6-GlcNAc-GlcNAc and Fuc-␣1,6-GlcNAc. (B) The synthetic process of Fuc-␣1,6-GlcNAc-GlcNAc (35). (C) The synthetic process of Fuc-␣1,6-GlcNAc
(details in Materials and Methods). (D) The growth curves of Bifidobacterium and Lactobacillus strains when cultured in liquid media supplemented with
chemically synthesized Fuc-␣1,6-GlcNAc-GlcNAc as the sole carbon source. (E) The growth curves of Bifidobacterium and Lactobacillus strains when cultured in
liquid media supplemented with chemically synthesized Fuc-␣1,6-GlcNAc as the sole carbon source. The oligosaccharide concentration was 10 mM. Growth was
monitored by measuring the OD546. Three technical replicates were performed for each strain. *, P Ͻ 0.05, **, P Ͻ 0.01, and ***, P Ͻ 0.001, by two-way ANOVA.
Core-fucosylated oligosaccharides promoted the growth of Bifidobacterium
and Lactobacillus spp. Lactobacillus and Bifidobacterium spp. were more abundant in
high-core-fucosylated milk-fed infants and Fut8ϩ/ϩ mouse-fed offspring, suggesting
that these bacteria might preferentially use core-fucosylated milk N-glycans. Fuc-␣1,6-
GlcNAc-GlcNAc and Fuc-␣1,6-GlcNAc are basic fucosyl structures on milk N-glycan
(Fig. 6A). Therefore, we chemically synthesized Fuc-␣1,6-GlcNAc-GlcNAc and Fuc-␣1,6-
GlcNAc (41) (Fig. 6B and C), and cultured several Bifidobacterium and Lactobacillus
strains (see Table S3 in the supplemental material) in liquid minimal medium supple-
mented with Fuc-␣1,6-GlcNAc and Fuc-␣1,6-GlcNAc-GlcNAc as the sole carbon source.
Interestingly, most bacteria grew in the Fuc-␣1,6-GlcNAc-GlcNAc-supplemented me-
dium (Fig. 6D), but only some of the Lactobacillus spp. (L. casei ATCC 334 and L. gasseri
ATCC 33323) survived in Fuc-␣1,6-GlcNAc-supplemented medium (Fig. 6E). These
results suggest that Lactobacillus strains have superior ability to hydrolyze the ␣1,6-
linkage-bond fucose.
DISCUSSION
Human milk glycans provide a broad range of carbon sources for gut microbes in
infants. In addition to HMOs, there are numerous N-glycans in human milk proteins,
March/April 2019 Volume 10 Issue 2 e00128-19
mbio.asm.org 11

®
Li et al.
which may impact the gut microbial composition of infants. Core fucosylation of
N-glycan is the most common posttranscriptional modification of proteins in mammals.
To our knowledge, this is the first study to systematically investigate the correlation
between maternal milk glycosylation and the gut microbiome of infants.
Fucosylated glycans have marked effects on human health through manipulation of
gut microbiota (42, 43). Many studies have found that the status of mothers’ secretor
gene Fut2 or Lewis blood-type-related gene Fut3 could influence the ␣1,2/3- or
␣1,3/4-fucosylation levels of HMOs and in turn affect the gut microbiota of their
breast-fed infants (15). Although the fucosylation of N-glycans in milk is also modified
by Fut2 and Fut3, but according to the glycoforms of human milk proteins detected by
multiple reaction monitoring (32), core fucosylation is the major fucosylation form of
human milk N-glycans, this was also proved by our mass spectrometry detection in milk
samples of Chinese mothers. By lectin blotting of milk protein, we found that the Fut8
gene SNP (A¡G mutation at rs10483776) of the enrolled Chinese mothers strongly
affected the fucosylation level of their milk N-glycans. On the other hand, when
measuring HMOs in these milk samples, we did not find any difference in the abun-
dances of total and major HMOs between groups A and G, which suggested that the
A¡G mutation in the Fut8 gene did not affect the fucosylation levels of HMOs. It is not
a surprise that the fucosylation of HMOs is mainly catalyzed by Fut2 and Fut3, while the
␣1,6-fucosylated glycotopes on milk glycoproteins (catalyzed by Fut8) were found to be
absent on HMOs (44, 45): thus, the differences in the gut microbiomes observed in
infants fed by the G and A groups of mothers were attributed to the different core
fucosylation levels of milk N-glycans.
In infants fed by mothers with high-fucosylated milk N-glycans, the Bifidobacteria,
mainly including B. pseudocatenulatum, B. bifidum, and B. breve, were dominant during
early lactation, which markedly contributed to the high proportion of Actinobacteria in
infants that possess the ability to use fucosylated glycans (46). These Bifidobacterium
spp. can be shared by mothers and their offspring as a source of probiotics (47, 48).
Furthermore, they have antagonistic activities on Gram-negative enteric pathogens (49)
and can improve the inflammatory status of insulin-resistant obese children (50). Other
more abundant microbial groups in infants fed by G group mothers, especially during
late lactation, included L. casei, L. mucosae, and L. gasseri, which are usually isolated
from infant feces (51, 52). L. casei possesses a strong ability to ferment milk glycans by
the expression of various GHs and gene clusters (53, 54). This strain also shows many
beneficial effects on infants such as growth promotion (55) and inhibition of pathogens
(56, 57). L. mucosae strains have been shown to decrease epithelial permeability and
improve epithelial barrier function. The presence of this organism provides competitive
exclusion against many pathogenic organisms and help with the development of new
probiotic food products (58). L. gasseri was found attenuated allergic airway inflamma-
tion through PPAR␥ (peroxisome proliferator-activated receptor gamma) activation in
dendritic cells (59). On the contrary, the gut of infants fed by mothers with low-
fucosylated-milk N-glycans were dominated by the order Clostridiales (at day 6) or the
genera of undefined Clostridiales and Pseudomonas (at day 120). Pseudomonas can be
an oral and enteric pathogen found dominant in preterm infants (60); overgrowth of
these bacteria may increase the risk of infection under immunocompromised condi-
tions (61). Clostridiales are in high prevalence in the first 2 weeks of life (62): this was
unfortunately known for a few pathogenic species that include Clostridium botulinum,
Clostridium perfringens, Clostridium tetani, and Clostridium difficile in the family Clostri-
diaceae (63). However, in our study, Clostridiales were largely overlooked because of the
difficulties to culture the organisms in vitro. Further understanding of the selective
nutritional requirement that favor the growth of these bacteria would be helpful to
study their effects on intestinal maturation and health outcomes in infants.
Mouse models can complement human studies and provide further insights into
how core fucosylation of milk N-glycans influences the gut microbiota composition and
the health outcome of breast-fed infants. Interestingly, a greater abundance of Lacto-
bacillus spp. (mainly L. gasseri and L. reuteri), Bacteroides spp., and Bifidobacterium spp.
March/April 2019 Volume 10 Issue 2 e00128-19
mbio.asm.org 12

®
Core Fucosylation of Milk N-Glycan Evokes B Cell
was detected in the neonates fed by Fut8ϩ/ϩ mice compared with those fed by Fut8ϩ/Ϫ
mice. Bacteroides spp. are glycan consumers (36): thus, our results also suggested their
ability to utilize fucosylated milk N-glycans. In contrast, the Fut8ϩ/Ϫ mouse-fed neo-
nates had more abundance of members of the Lachnospiraceae NK4A136 group and
Akkermansia spp. than those fed by Fut8ϩ/ϩ mice. Lachnospiraceae abundance in gut
of infants was found to be significantly associated with higher body mass index (BMI)
and with increased odds of being overweight or obesity (64). However, the presence of
the Lachnospiraceae NK4A136 group was negatively correlated with intestinal inflam-
mation (65). Thus, the functions of this group of bacteria deserve further investigation.
Akkermansia, especially the species Akkermansia muciniphila, is known as an intestinal
mucin-degrading bacterium (66). Although positive correlations were observed be-
tween fucosylated HMOs and A. muciniphila (67), this genus was also found to be
significantly enriched in infants with eczema (68). It was speculated that higher
abundance of A. muciniphila in eczematous infants might reduce the integrity of
intestinal barrier function and therefore increase the risk of developing eczema. Based
on the above information, our results found in the neonatal mice suggested an
alteration of gut microbiota toward a probably unhealthy pattern in response to
changes in core fucosylation levels of maternal milk N-glycans.
As the aberrant neonatal microbiota composition can elicit abnormal immune
responses, we therefore further investigated the major immune organs of the neonates
fed by Fut8ϩ/ϩ or Fut8ϩ/Ϫ mice. Indeed, a significantly smaller population of total
lymphocytes in the thymus and spleen of neonates fed by Fut8ϩ/Ϫ mice was detected
compared with those fed by Fut8ϩ/ϩ mice. These neonates also exhibited a significantly
lower proportion of active B cells in their spleen, resulted in attenuated IgG production
after OVA stimulation. Of concern, since microbiota suppression by MixAbx treatment
in the offspring mice hindered the development of B cells, regardless of whether
the offspring were fed by Fut8ϩ/ϩ or Fut8ϩ/Ϫ mice, it is reasonable to think that the
core-fucosylated milk N-glycan may regulate neonatal B cell responses through gut
microbiota modulation.
Kim et al. (11) reported that gut microbiota-derived SCFAs activated B cells by
increasing acetyl-CoA and regulating metabolic sensors to increase oxidative phos-
phorylation, glycolysis, and fatty acid synthesis, which produce energy and factors
required for antibody production, but how B cells interact or import these factors
remain unclear. Interestingly, in our study, stimulation of 1,2-propanediol and lactate,
the L-fucose metabolites of B. pseudocatenulatum, L. casei, and L. gasseri, to mouse
PP-derived lymphocytes resulted in a marked elevation of B cell activation. These
suggested a novel way of probiotic bacteria in immune regulation other than through
the production of SCFAs. BCR-mediated immune responses to antigen (Ag) stimulation
regulate several biological functions, including B cell activation and differentiation. To
further study the mechanisms, the 3-83 B cell line was adopted. We found that
1,2-propanediol and lactate could initiate the BCR signaling of 3-83 B cells, which plays
an important role in the maturation and survival of B cell lineages, and the consequen-
tial humoral immune responses (69). This explains the phenomena we observed in
Fut8ϩ/Ϫ mouse-fed neonates, where the relatively reduced B cell proportion resulted in
the downregulation of humoral immunity post-OVA stimulation. Our study thus high-
lighted a novel mechanism whereby L-fucose metabolites, mainly 1,2-propanediol (37,
38), interacted directly with BCR molecules to promote B cell activation. Further
molecular studies regarding the interaction between 1,2-propanediol and BCR may
contribute to the elucidation of the underlying mechanisms.
To elucidate how core fucose on milk N-glycan selectively promotes the growth of
Bifidobacterium and Lactobacillus spp., Fuc-␣1,6-GlcNAc and Fuc-␣1,6-GlcNAc-GlcNAc
were synthesized chemically. Fucosylated oligosaccharide is an important core struc-
ture that forms part of human mucosal and milk glyco-complexes (70–72). The distinc-
tive ␣1,6 linkage of fucose on N-GlcNAc may contribute to its selective effects. Previous
studies showed that Lactobacillus casei fermented the N-GlcNAc moiety of Fuc-␣1,6-
GlcNAc and excreted L-fucose (73). It harbors a novel ␣-L-fucosidase (AflC) gene which
March/April 2019 Volume 10 Issue 2 e00128-19
mbio.asm.org 13

®
Li et al.
specifically hydrolyzes natural ␣1,6-linked fucosyl-oligosaccharides in vitro (74). This
might explain why L. casei is more abundant in infants fed by mothers with high-core-
fucosylated milk N-glycan. However, compared with oligosaccharides, the structure of
protein N-glycans is more complicated. Bacterium-derived fucosidases were reported to
have very low activity in decomposing the ␣-1,6-bond core fucose (75). Fuc-␣1,6-
GlcNAc can only be hydrolyzed by ␣-L-fucosidases with the assistance of endo-N-
acetylglucosidases (Endo), which hydrolyzes the N-glycans between two adjacent
N-GlcNAc. Some bifidobacteria express Endo-like enzymes, which allows them to
become dominant in the intestines of infants by using milk N-glycans (18). Endos
mainly belong to the GH18 and GH85 families; they are also found in the genomes
of other gut microbes, such as multiple species of Bacteroides (accession no.
WP_048696603.1; GI no. 880967032), Enterococcus faecalis (accession no.: AAO82555.1;
GI no. 29344798), and Lactobacillus spp. (accession no. YP_004888239.1; GI no.
1061453). Indeed, we found that GH18 genes were upregulated in the gut of infants fed
by mothers with high-core-fucosylated-milk N-glycans (Fig. 2E). Thus, use of synthetic
Fuc-␣1,6-GlcNAc and Fuc-␣1,6-GlcNAc-GlcNAc by L. casei and L. gasseri suggests the
coexpression of Endo and AflC-like enzymes in their genomes and their superiority
when competing with other gut microbes. However, when Fuc-␣1,6-GlcNAc was incu-
bated with Bifidobacterium spp., no obvious growth-promoting effects were detected,
although ␣-L-fucosidase genes were also found in the genomes of Bifidobacterium spp.,
but with poor activity for hydrolyzing the ␣1,6-linkage-bond fucose (75). Therefore, the
substantially greater proportion of bifidobacteria in infants fed by mothers with high-
core-fucosylated milk N-glycan may due to excreted L-fucose by Lactobacillus spp. This
suggests a synergism between Lactobacillus and Bifidobacterium in digesting milk
N-glycans in the gut of infants. However, more studies are needed to define in detail
the mechanism how Lactobacillus and Bifidobacterium specifically consume core-
fucosylated N-glycan and impact immune development of infants.
Conclusions. Infants fed by mothers with higher-core-fucosylated milk N-glycans (G
group) harbored greater abundance of Bifidobacterium spp. and Lactobacillus spp. and
reduced abundance of Clostridiales and Pseudomonas during lactation. Compared with
Fut8ϩ/ϩ mouse-fed neonates, the neonates fed by Fut8ϩ/Ϫ mice were characterized by
reduced abundance of Lactobacillus spp., Bacteriodes spp., and Bifidobacterium spp. and
increased abundance of members of the Lachnospiraceae NK4A136 group and Akker-
mansia spp. in their gut: these neonates also exhibited a lower proportion of active B
cells in spleen. In vitro study showed that 1,2-propanediol and lactate, the metabolites
of L-fucose produced by Lactobacillus and Bifidobacterium spp., could evoke B cell
activation through the BCR-mediated signaling pathway. The chemically synthesized
core-fucosylated oligosaccharides showed the ability to promote the growth of Lacto-
bacillus and Bifidobacterium spp., and therefore could be considered a promising
prebiotic for the personalized nutrition of infants (Fig. 7).
MATERIALS AND METHODS
Subjects and sample collection. The study was approved by the ethical committees of Dalian
Medical University, Dalian, China. A subset of 56 infant/mother dyads from the First Affiliated Hospital of
Jinzhou Medical University was selected. Written informed consent was obtained from the parents before
enrollment. Subjects were enrolled at approximately 34 weeks of gestation and asked to fill out detailed
health history questionnaires. To eliminate the interference of delivery mode and feeding pattern on gut
microbiome of infants, only mothers who gave birth by vaginal delivery and exclusively breast-fed were
enrolled (Table 1). The milk and fecal samples were collected as described before (15) and immediately
stored at Ϫ20°C until they were transported to the laboratory on dry ice, where they were stored at
Ϫ80°C prior to use. The milk and feces samples were collected by days 6, 42, and 120 postpartum.
Normally 3 days postpartum, the mothers start to lactate, and by day 6, their babies had been fed for at
least 3 days; in addition, by that time the mothers have enough milk for sampling. Day 42 is after
puerperium, which is the period of adjustment after delivery when the anatomic and physiological
changes of pregnancy are reversed and the body returns to the normal nonpregnant state; normally
Chinese mothers are asked to go back to the hospital for routine checkup. In addition, according to a
previous study (76), from week 4 to week 8 after birth, some microbial groups in the gut of infants
significantly increase in proportion: day 42 (6 weeks postpartum) is in the middle of this period. We
collected the samples by day 120 postpartum to detect the long-term development of gut microbiota
in infants and also to ensure the infants were exclusively breastfeeding, because many of the infants
March/April 2019 Volume 10 Issue 2 e00128-19
mbio.asm.org 14

®
Core Fucosylation of Milk N-Glycan Evokes B Cell
FIG 7 Highlights of this study. (A) Infants fed by mothers with higher-core-fucosylated milk N-glycans (affected by Fut8 gene status) harbored more abundance
of Bifidobacterium and Lactobacillus spp. and reduced abundance of Clostridiales and Pseudomonas spp. during lactation. (B) The neonates fed by Fut8ϩ/Ϫ mice
were characterized by reduced abundance of Lactobacillus, Bacteriodes, and Bifidobacterium spp. and increased abundance of members of the Lachnospiraceae
NK4A136 group and Akkermansia spp. in their gut; these neonates also exhibited a lower proportion of active B cells in spleen. (C) Bifidobacterium and
Lactobacillus strains can utilize chemically synthesized core-fucosylated oligosaccharides. Genes encoding Endo and ␣1,6-fucosidase in the genome of these
bacteria are key genetic factors for the use of core fucose, and the resulting metabolites, 1,2-propanediol and lactate, promoted the activation of B cells via
the BCR-mediated signaling pathway.
were introduced to formula or complementary foods after 4 months postpartum. All of the infants
consumed breast milk only, and infants who received antibiotics, probiotics, or formula powder because
of diseases or lack of breast milk were excluded during the study period.
Detection of milk N-glycan and HMOs by mass spectrometer. The milk N-glycan detection was
carried out using an LTQ-XL linear ion trap electrospray ionization mass spectrometer (ESI-MS) coupled
with a high-performance liquid chromatography (HPLC) system (Thermo Scientific, USA), as described
previously (77). The HMOs were detected by a newly developed method based on a zwitterionic LC
matrix with a mixed-mode action of hydrophilic interaction with cation exchange for cleanup and
separation of HMOs (13, 78). The neutral sugars were eluted, and acidic HMOs were resolved and
identified. Particularly, we used a different column material (named ASP; 150 mm by 2.1-mm inside
diameter [i.d.]) to allow acidic sugars to be eluted first, and focused on detailed separation and neutral
HMOs. HMO identification and quantification were performed via Agilent Mass Hunter Qualitative
Analysis software (version B.03.01) (detailed in Text S1 in the supplemental material).
SNPs. DNA was extracted from breast milk using the Qiagen DNeasy blood and tissue kit (Qiagen,
Venlo, The Netherlands). Genomic DNA purified from each mother’s breast milk was amplified with
primers Fut8-F (5=-TAT AAA GGC ACA GAA ACA GAC A) and Fut8-R (5=-TTG ATG GTG GCT CCA TTG CC),
which produces a 337-bp amplicon containing the mutated rs10483776 SNP (A¡G) allele of the Fut8
gene. Successful amplification was confirmed by gel electrophoresis, and the PCR products were sent to
the sequencing company (Sangon Biotech) for DNA sequence detection.
FUT8 enzyme activity assay. Cells isolated from human milk and mouse mammary gland were
suspended in 20 ␮l lysis buffer containing 10 mM Tris-HCl (pH 7.4), 150 mM NaCl, and 1% Triton X-100.
The cell lysate was assayed for Fut8 activity by HPLC, as described previously (23).
Western blot and lectin blot analysis. Each milk sample was defatted via centrifugation at
8,000 rpm for 10 min. After that, 1 ␮l of skim milk was taken and dissolved in 30 ␮l protein loading buffer
(250 mM Tris-HCl [pH 6.8], 0.5% bromophenol blue, 50% glycerol, 10% SDS, 5% ␤-mercaptoethanol), and
then 10 ␮l of proteins was subjected to SDS-PAGE. After SDS-PAGE, the proteins were transferred to
polyvinylidene difluoride (PVDF) membranes for immunoblotting or lectin blotting after incubation with
the appropriate primary antibodies (Abs for human LF, IgG, and IgA were purchased from Abcom) or
biotin-conjugated AOL (Seikagaku, Tokyo, Japan) (23).
Fecal DNA extraction, 16S rRNA, and metagenomic sequencing. The microbial genome DNA from
fecal samples of infants and mice was extracted using the E.Z.N.A. stool DNA kit (Omega Bio-tek, Inc.)
March/April 2019 Volume 10 Issue 2 e00128-19
mbio.asm.org 15

®
Li et al.
according to the manufacturer’s instructions. The library construction, qualification, and sequencing were
done by Illumina HiSeq (Novogene Bioinformatics Technology Co., Ltd., Beijing, China) (79); for details
regarding 16S rRNA and metagenomic sequencing, please see Text S1.
Mice. Heterozygous Fut8ϩ/Ϫ mice on the ICR background were maintained in a room illuminated for
12 h (08:00 to 20:00 h) and kept at 24 Ϯ 1°C with free access to food and water in the specific-pathogen-
free laboratory animal facility of Dalian Medical University. All of the animal experiments were conducted
according to the Guide for the Care and Use of Laboratory Animals (NIH publication no. 8023 [80]). Each
Fut8ϩ/Ϫ and Fut8ϩ/ϩ maternal mouse nurtured three female neonates (n ϭ 3).
Flow cytometric analysis. Thymus, spleen, and intestinal PPs of mice were picked up and ground
in phosphate-buffered saline (PBS), and 1 ϫ 106 cells were used for flow cytometry with a fluorescence-
activated cell sorter (FACS). Cells were incubated with anti-mouse CD16/CD32 monoclonal antibody
(MAb) to block Fc␥ receptors for 15 min and then stained on ice for 30 min with combinations of MAbs,
as indicated in the figure legends. The MAbs used in this study are anti-mouse CD16/CD32 (2.4G2),
phycoerythrin (PE)-conjugated Cy5-labeled anti-mouse CD4 (GK1.5), allophycocyanin (APC)-labeled anti-
mouse CD8 (53-6.7), PE-labeled anti-mouse CD3 (2C11), PE-Cy5-labeled anti-mouse CD19 (6D5), fluores-
cein isothiocyanate (FITC)-labeled anti-mouse CD69 (H1.2F3), FITC-labeled anti-mouse Gr-1 (8C5), PE-
labeled anti-mouse CD11c (N418), FITC-labeled anti-mouse pan-NK cells (DX5), PE-labeled anti-mouse
F4/80 (BM8), and APC-labeled anti-mouse erythroid cells (TER119), all purchased from BD Biosciences.
The flow cytometry assay was performed on a FACS-Calibur (Becton Dickinson, Mountain View, CA) and
analyzed using FlowJo sofware (Tree Star).
Synthesis of Fuc-␣1,6-GlcNAc and Fuc-␣1,6-GlcNAc-GlcNAc. The synthetic route of Fuc-␣1,6-
GlcNAc-GlcNAc was described in our previous study (41). The synthetic route of the disaccharide
Fuc-␣1,6-GlcNAc (23) starts from the raw material of 1-␤-azido-2-acetylamino-2-deoxy-3,4,6-O-triacetyl-
D-glucopyranoside (compound 19). Compound 19 was dissolved in methanol and treated with NaOMe
for 2 h at room temperature to give 1-␤-azido-2-acetylamino-2-deoxy-D-glucopyranoside. The obtained
product reacted with trityl chloride and pyridine to give 1-␤-azido-2-acetylamino-2-deoxy-6-O-trityl-D-
glucopyranoside. Then, it was treated with benzoyl chloride and pyridine to give 1-␤-azido-2-
acetylamino-2-deoxy-3,4-O-dibenzoyl-6-O-trityl-D-glucopyranoside (compound 20). Compound 20 was
treated with AcOH-H2O to remove the 6-trityl and give compound 21. The glycosylation reaction of
compound 21 and compound 14 was carried out in the presence of a sterically hindered base,
2,6-di-tert-butyl-pyridine, to give disaccharide 22. After debenzoylation with NaOMe and next-step
reduction of the azido group, disaccharide 23 was created.
Growth of strains in the presence of synthetic oligosaccharides. The standard strains used in this
study were obtained from China General Microbiological Culture Collection Center (CGMCC). They were
routinely grown at 37°C on MRS medium supplemented with 0.1% L-cysteine and under anaerobic
conditions. The strains were diluted to an optical density at 546 nm (OD546) of 0.1 in 1 ml of sugar-free
MRS basal medium (73) containing 10 mM Fuc-␣1,6-GlcNAc-GlcNAc or Fuc-␣1,6-GlcNAc. Growth was
monitored by measuring the OD546. Three technical replicates were performed for each strain.
Cells and culture conditions. The 3-83 B cells (expressing IgG2a-BCR recognizing p31) were
purchased from the American Type Culture Collection. Cells were grown in RPMI 1640 supplemented
with 2 mM glutamine, 50 mM 2-mercaptoethanal (ME) (Fluka, Buchs, Switzerland), 5% fetal calf serum
(FCS), 100 U/ml penicillin, and 100 mg/ml streptomycin.
In order to detect the activation of B cells, approximately 1 ϫ 106 cells were cultured in serum-free
medium for 12 h. Then, p31, 1,2-propanediol, and lactate were added to serum-free medium, respec-
tively, at 1 and 10 ␮g/ml, for 5 min at room temperature. After that, cells were solubilized in lysis buffer
(50 mM Tris-HCl [pH 8], 1% [vol/vol] Triton X-100, 150 mM NaCl, 10% [vol/vol] glycerol, 2 mM EDTA,
100 mM phenylmethylsulfonyl fluoride [PMSF], 5 mg/ml leupeptin, 1 mg/ml aprotinin, 100 mM NaF, and
1 mM sodium orthovanadate). Insoluble debris was removed after centrifugation at 10,000 ϫ g for 10 min
at 4°C. The same amounts of samples were separated by 10% SDS-PAGE and transferred to PVDF film.
After blocking with 5% bovine serum albumin (BSA) for 1 h, the films were incubated in sequence with
primary antibodies (Syk [D3Z1E] rabbit MAb, phospho-Syk [Tyr323] Ab, phospho-p44/42 MAPK [Erk1/2;
Thr202/Tyr204] Ab, and p44/42 MAPK [Erk1/2] Ab, all purchased from Cell Signaling) overnight at 4°C and
then with appropriate secondary antibodies (horseradish peroxidase [HRP]-conjugated goat anti-rabbit
and anti-mouse IgG, purchased from Proteintech). Density analysis was performed using Quantity One
software.
Molecular interaction detection by Biacore. BCR molecules were purified according to the method
described in reference 41. The interactions between BCR and L-fucose metabolites were performed at
room temperature using a BIAcoreT100 system with CM5 chips (GE Healthcare). An HBS-EP buffer
consisting of 150 mM NaCl, 10 mM HEPES (pH 7.4), and 0.005% (vol/vol) Tween 20 was used as running
buffer. The blank channel of the chip served as the negative control. To measure the interaction between
L-fucose metabolites and BCR, 1 ␮g/ml BCR protein was immobilized on the chip. Gradient concentra-
tions of lactate and 1,2-propanediol were then flowed over the chip surface. The binding kinetics were
analyzed with the software BIA Evaluation version 4.1 using a 1:1 Langmuir-binding model (81).
Statistical analysis. The comparisons between two groups were performed using an unpaired
Student’s t test with Welch’s correction by Graph Pad Prism version 5 (Graph Pad Software, La Jolla, CA).
The data are shown as mean Ϯ standard error of the mean (SEM). P values of Ͻ0.05 are considered
statistically significant (*, P Ͻ 0.05; **, P Ͻ 0.01; ***, P Ͻ 0.001). For gut microbiota analysis, the Chao1
index and the Shannon index at the genus level were calculated with QIIME (version 1.7.0). The
abundance and diversity of the OTUs (beta diversity) were examined using principal-coordinate analysis
(PCoA) with unweighted UniFrac analysis in R software. LEfSe was used with the Kruskal-Wallis rank sum
March/April 2019 Volume 10 Issue 2 e00128-19
mbio.asm.org 16

®
Core Fucosylation of Milk N-Glycan Evokes B Cell
test to detect features with significantly different abundances between assigned taxa, and linear
discriminant analysis (LDA) was performed to estimate the effect size of each feature. Bacterial groups
with an LDA score of м4.00 were shown as significantly abundant within the indicated group. Data
correlating to differential abundances of KEGG modules and CAZy enzymes were tested by Wilcoxon’s
rank sum test, and P values were corrected for multiple testing by the Benjamin and Hochberg method.
The bacterial genes with an LDA score of м2.5 were shown as significantly abundant in the indicated
group. Statistical analysis of the quantitative multiple-group comparisons was performed using one-way
analysis of variance (ANOVA [and nonparametric test]), followed by Tukey’s test (to compare all pairs of
columns) with the assistance of GraphPad Prism 5. When analyzing the growth of mice or bacteria,
two-way ANOVA were performed with the assistance of GraphPad Prism 5.
Data availability. The sequencing data were deposited in NCBI SRA under the accession number
PRJNA527059.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.00128-19.
TEXT S1, DOCX file, 0.1 MB.
FIG S1, PDF file, 0.1 MB.
FIG S2, TIF file, 2.2 MB.
FIG S3, TIF file, 0.9 MB.
FIG S4, TIF file, 5 MB.
FIG S5, TIF file, 0.7 MB.
FIG S6, TIF file, 0.1 MB.
TABLE S1, DOCX file, 0.1 MB.
TABLE S2, DOCX file, 0.1 MB.
TABLE S3, DOCX file, 0.1 MB.
ACKNOWLEDGMENTS
This work was supported by grants from the National Natural Science Foundation of
China (31570797 and 31870797), the Nutrition and Care of Maternal & Child Research
Fund Project of Guangzhou Biostime Institute of Nutrition & Care (2018BINCMCF39 and
2016BINCMCF1102), and the Research Foundation from the Department of Education,
Liaoning Province, China (L2016003). This work was also supported by Liaoning Pro-
vincial Program for Top Discipline of Basic Medical Sciences, China.
All the authors declare they have no competing interests.
REFERENCES
1. Zivkovic AM, German JB, Lebrilla CB, Mills DA. 2011. Human milk glyco-
biome and its impact on the infant gastrointestinal microbiota. Proc Natl
Acad Sci U S A 108(Suppl 1):4653–4658. https://doi.org/10.1073/pnas
.1000083107.
2. Charbonneau MR, O’Donnell D, Blanton LV, Totten SM, Davis JC, Barratt
MJ, Cheng J, Guruge J, Talcott M, Bain JR, Muehlbauer MJ, Ilkayeva O, Wu
C, Struckmeyer T, Barile D, Mangani C, Jorgensen J, Fan YM, Maleta K,
Dewey KG, Ashorn P, Newgard CB, Lebrilla C, Mills DA, Gordon JI. 2016.
Sialylated milk oligosaccharides promote microbiota-dependent growth
in models of infant undernutrition. Cell 164:859–871. https://doi.org/10
.1016/j.cell.2016.01.024.
3. Victora CG, Bahl R, Barros AJ, Franca GV, Horton S, Krasevec J, Murch S,
Sankar MJ, Walker N, Rollins NC. 2016. Breastfeeding in the 21st century:
epidemiology, mechanisms, and lifelong effect. Lancet 387:475–490.
https://doi.org/10.1016/S0140-6736(15)01024-7.
4. Piper KM, Berry CA, Cregan MD. 2007. The bioactive nature of human
breastmilk. Breastfeed Rev 15:5–10.
5. Nishiyama K, Yamamoto Y, Sugiyama M, Takaki T, Urashima T, Fukiya S,
Yokota A, Okada N, Mukai T. 2017. Bifidobacterium bifidum extracellular
sialidase enhances adhesion to the mucosal surface and supports car-
bohydrate assimilation. mBio 8:e00928-17. https://doi.org/10.1128/mBio
.00928-17.
6. Madan JC, Hoen AG, Lundgren SN, Farzan SF, Cottingham KL, Morrison
HG, Sogin ML, Li H, Moore JH, Karagas MR. 2016. Association of Cesarean
delivery and formula supplementation with the intestinal microbiome of
6-week-old infants. JAMA Pediatr 170:212–219. https://doi.org/10.1001/
jamapediatrics.2015.3732.
7. Backhed F, Roswall J, Peng Y, Feng Q, Jia H, Kovatcheva-Datchary P, Li Y,
Xia Y, Xie H, Zhong H, Khan MT, Zhang J, Li J, Xiao L, Al-Aama J, Zhang
D, Lee YS, Kotowska D, Colding C, Tremaroli V, Yin Y, Bergman S, Xu X,
Madsen L, Kristiansen K, Dahlgren J, Wang J. 2015. Dynamics and
stabilization of the human gut microbiome during the first year of life.
Cell Host Microbe 17:852. https://doi.org/10.1016/j.chom.2015.05.012.
8. Le Doare K, Holder B, Bassett A, Pannaraj PS. 2018. Mother’s milk: a
purposeful contribution to the development of the infant microbiota
and immunity. Front Immunol 9:361. https://doi.org/10.3389/fimmu
.2018.00361.
9. Tamburini S, Shen N, Wu HC, Clemente JC. 2016. The microbiome in
early life: implications for health outcomes. Nat Med 22:713–722. https://
doi.org/10.1038/nm.4142.
10. Adkins B, Du RQ. 1998. Newborn mice develop balanced Th1/Th2 pri-
mary effector responses in vivo but are biased to Th2 secondary re-
sponses. J Immunol 160:4217–4224.
11. Kim M, Qie Y, Park J, Kim CH. 2016. Gut microbial metabolites fuel host
antibody responses. Cell Host Microbe 20:202–214. https://doi.org/10
.1016/j.chom.2016.07.001.
12. Pacheco AR, Barile D, Underwood MA, Mills DA. 2015. The impact of the
milk glycobiome on the neonate gut microbiota. Annu Rev Anim Biosci
3:419–445. https://doi.org/10.1146/annurev-animal-022114-111112.
13. Yan J, Ding J, Jin G, Yu D, Yu L, Long Z, Guo Z, Chai W, Liang X. 2018.
Profiling of sialylated oligosaccharides in mammalian milk using online
solid phase extraction-hydrophilic interaction chromatography cou-
pled with negative-ion electrospray mass spectrometry. Anal Chem
90:3174–3182. https://doi.org/10.1021/acs.analchem.7b04468.
March/April 2019 Volume 10 Issue 2 e00128-19
mbio.asm.org 17

®
Li et al.
14. Martin-Ortiz A, Barile D, Salcedo J, Moreno FJ, Clemente A, Ruiz-Matute
AI, Sanz ML. 2017. Changes in caprine milk oligosaccharides at different
lactation stages analyzed by high performance liquid chromatography
coupled to mass spectrometry. J Agric Food Chem 65:3523–3531.
https://doi.org/10.1021/acs.jafc.6b05104.
15. Lewis ZT, Totten SM, Smilowitz JT, Popovic M, Parker E, Lemay DG, Van
Tassell ML, Miller MJ, Jin YS, German JB, Lebrilla CB, Mills DA. 2015.
Maternal fucosyltransferase 2 status affects the gut bifidobacterial com-
munities of breastfed infants. Microbiome 3:13. https://doi.org/10.1186/
s40168-015-0071-z.
16. Collin M, Fischetti VA. 2004. A novel secreted endoglycosidase from
Enterococcus faecalis with activity on human immunoglobulin G and
ribonuclease B. J Biol Chem 279:22558–22570. https://doi.org/10.1074/
jbc.M402156200.
17. Allhorn M, Olin AI, Nimmerjahn F, Collin M. 2008. Human IgG/Fc gamma
R interactions are modulated by streptococcal IgG glycan hydrolysis.
PLoS One 3:e1413. https://doi.org/10.1371/journal.pone.0001413.
18. Karav S, Le Parc A, Leite Nobrega de Moura Bell JM, Frese SA, Kirmiz N,
Block DE, Barile D, Mills DA. 2016. Oligosaccharides released from milk
glycoproteins are selective growth substrates for infant-associated bifi-
dobacteria. Appl Environ Microbiol 82:3622–3630. https://doi.org/10
.1128/AEM.00547-16.
19. Garrido D, Nwosu C, Ruiz-Moyano S, Aldredge D, German JB, Lebrilla CB,
Mills DA. 2012. Endo-beta-N-acetylglucosaminidases from infant gut-
associated bifidobacteria release complex N-glycans from human milk
glycoproteins. Mol Cell Proteomics 11:775–785. https://doi.org/10.1074/
mcp.M112.018119.
20. Nwosu CC, Aldredge DL, Lee H, Lerno LA, Zivkovic AM, German JB,
Lebrilla CB. 2012. Comparison of the human and bovine milk N-glycome
via high-performance microfluidic chip liquid chromatography and tan-
dem mass spectrometry. J Proteome Res 11:2912–2924. https://doi.org/
10.1021/pr300008u.
21. Barboza M, Pinzon J, Wickramasinghe S, Froehlich JW, Moeller I, Smilow-
itz JT, Ruhaak LR, Huang J, Lonnerdal B, German JB, Medrano JF, Weimer
BC, Lebrilla CB. 2012. Glycosylation of human milk lactoferrin exhibits
dynamic changes during early lactation enhancing its role in pathogenic
bacteria-host interactions. Mol Cell Proteomics 11:M111.015248. https://
doi.org/10.1074/mcp.M111.015248.
22. Yamaguchi Y, Ikeda Y, Takahashi T, Ihara H, Tanaka T, Sasho C, Uozumi
N, Yanagidani S, Inoue S, Fujii J, Taniguchi N. 2000. Genomic structure
and promoter analysis of the human alpha1, 6-fucosyltransferase gene
(FUT8). Glycobiology 10:637–643. https://doi.org/10.1093/glycob/10.6
.637.
23. Liang W, Mao S, Sun S, Li M, Li Z, Yu R, Ma T, Gu J, Zhang J, Taniguchi
N, Li W. 2018. Core fucosylation of the T cell receptor is required for
T cell activation. Front Immunol 9:78. https://doi.org/10.3389/fimmu
.2018.00078.
24. Wang X, Gu J, Ihara H, Miyoshi E, Honke K, Taniguchi N. 2006. Core
fucosylation regulates epidermal growth factor receptor-mediated intra-
cellular signaling. J Biol Chem 281:2572–2577. https://doi.org/10.1074/
jbc.M510893200.
25. Iijima J, Kobayashi S, Kitazume S, Kizuka Y, Fujinawa R, Korekane H,
Shibata T, Saitoh SI, Akashi-Takamura S, Miyake K, Miyoshi E, Taniguchi
N. 2017. Core fucose is critical for CD14-dependent Toll-like receptor 4
signaling. Glycobiology 27:1006–1015. https://doi.org/10.1093/glycob/
cwx075.
26. Huang J, Guerrero A, Parker E, Strum JS, Smilowitz JT, German JB, Lebrilla
CB. 2015. Site-specific glycosylation of secretory immunoglobulin A from
human colostrum. J Proteome Res 14:1335–1349. https://doi.org/10
.1021/pr500826q.
27. Li W, Yu R, Ma B, Yang Y, Jiao X, Liu Y, Cao H, Dong W, Liu L, Ma K, Fukuda
T, Liu Q, Ma T, Wang Z, Gu J, Zhang J, Taniguchi N. 2015. Core fucosy-
lation of IgG B cell receptor is required for antigen recognition and
antibody production. J Immunol 194:2596–2606. https://doi.org/10
.4049/jimmunol.1402678.
28. Arnold JN, Wormald MR, Suter DM, Radcliffe CM, Harvey DJ, Dwek RA,
Rudd PM, Sim RB. 2005. Human serum IgM glycosylation: identification
of glycoforms that can bind to mannan-binding lectin. J Biol Chem
280:29080–29087. https://doi.org/10.1074/jbc.M504528200.
29. Li W, Ishihara K, Yokota T, Nakagawa T, Koyama N, Jin J, Mizuno-
Horikawa Y, Wang X, Miyoshi E, Taniguchi N, Kondo A. 2008. Reduced
alpha4beta1 integrin/VCAM-1 interactions lead to impaired pre-B cell
repopulation in alpha 1,6-fucosyltransferase deficient mice. Glycobiol-
ogy 18:114–124. https://doi.org/10.1093/glycob/cwm107.
30. Fukuda T, Hashimoto H, Okayasu N, Kameyama A, Onogi H, Nakaga-
wasai O, Nakazawa T, Kurosawa T, Hao Y, Isaji T, Tadano T, Narimatsu H,
Taniguchi N, Gu J. 2011. Alpha1,6-fucosyltransferase-deficient mice ex-
hibit multiple behavioral abnormalities associated with a schizophrenia-
like phenotype: importance of the balance between the dopamine and
serotonin systems. J Biol Chem 286:18434–18443. https://doi.org/10
.1074/jbc.M110.172536.
31. Wang X, Fukuda T, Li W, Gao CX, Kondo A, Matsumoto A, Miyoshi E,
Taniguchi N, Gu J. 2009. Requirement of Fut8 for the expression of
vascular endothelial growth factor receptor-2: a new mechanism for the
emphysema-like changes observed in Fut8-deficient mice. J Biochem
145:643–651. https://doi.org/10.1093/jb/mvp022.
32. Huang J, Kailemia MJ, Goonatilleke E, Parker EA, Hong Q, Sabia R,
Smilowitz JT, German JB, Lebrilla CB. 2017. Quantitation of human milk
proteins and their glycoforms using multiple reaction monitoring
(MRM). Anal Bioanal Chem 409:589–606. https://doi.org/10.1007/s00216
-016-0029-4.
33. Ishida H, Moritani T, Hata Y, Kawato A, Suginami K, Abe Y, Imayasu S.
2002. Molecular cloning and overexpression of fleA gene encoding a
fucose-specific lectin of Aspergillus oryzae. Biosci Biotechnol Biochem
66:1002–1008. https://doi.org/10.1271/bbb.66.1002.
34. Huffman JE, Knezevic A, Vitart V, Kattla J, Adamczyk B, Novokmet M, Igl
W, Pucic M, Zgaga L, Johannson A, Redzic I, Gornik O, Zemunik T, Polasek
O, Kolcic I, Pehlic M, Koeleman CA, Campbell S, Wild SH, Hastie ND,
Campbell H, Gyllensten U, Wuhrer M, Wilson JF, Hayward C, Rudan I,
Rudd PM, Wright AF, Lauc G. 2011. Polymorphisms in B3GAT1, SLC9A9
and MGAT5 are associated with variation within the human plasma
N-glycome of 3533 European adults. Hum Mol Genet 20:5000–5011.
https://doi.org/10.1093/hmg/ddr414.
35. Paviour S, Musaad S, Roberts S, Taylor G, Taylor S, Shore K, Lang S,
Holland D. 2002. Corynebacterium species isolated from patients with
mastitis. Clin Infect Dis 35:1434–1440. https://doi.org/10.1086/344463.
36. Schwalm ND, III, Groisman EA. 2017. Navigating the gut buffet: control
of polysaccharide utilization in Bacteroides spp. Trends Microbiol 25:
1005–1015. https://doi.org/10.1016/j.tim.2017.06.009.
37. Bunesova V, Lacroix C, Schwab C. 2016. Fucosyllactose and L-fucose
utilization of infant Bifidobacterium longum and Bifidobacterium kashi-
wanohense. BMC Microbiol 16:248. https://doi.org/10.1186/s12866-016
-0867-4.
38. Becerra JE, Yebra MJ, Monedero V. 2015. An L-fucose operon in the
probiotic Lactobacillus rhamnosus GG is involved in adaptation to gas-
trointestinal conditions. Appl Environ Microbiol 81:3880–3888. https://
doi.org/10.1128/AEM.00260-15.
39. Testi R, Pulcinelli F, Frati L, Gazzaniga PP, Santoni A. 1990. CD69 is
expressed on platelets and mediates platelet activation and aggrega-
tion. J Exp Med 172:701–707. https://doi.org/10.1084/jem.172.3.701.
40. Mocsai A, Ruland J, Tybulewicz VL. 2010. The SYK tyrosine kinase: a
crucial player in diverse biological functions. Nat Rev Immunol 10:
387–402. https://doi.org/10.1038/nri2765.
41. Cai D, Xun C, Tang F, Tian X, Yang L, Ding K, Li W, Le Z, Huang W. 2017.
Glycoconjugate probes containing a core-fucosylated N-glycan trisac-
charide for fucose lectin identification and purification. Carbohydr Res
449:143–152. https://doi.org/10.1016/j.carres.2017.07.011.
42. Korpela K, Salonen A, Hickman B, Kunz C, Sprenger N, Kukkonen K,
Savilahti E, Kuitunen M, de Vos WM. 2018. Fucosylated oligosaccharides in
mother’s milk alleviate the effects of caesarean birth on infant gut micro-
biota. Sci Rep 8:13757. https://doi.org/10.1038/s41598-018-32037-6.
43. Li S, Li J, Mao G, Hu Y, Ye X, Tian D, Linhardt RJ, Chen S. 2018.
Fucosylated chondroitin sulfate oligosaccharides from Isostichopus ba-
dionotus regulates lipid disorder in C57BL/6 mice fed a high-fat diet.
Carbohydr Polym 201:634–642. https://doi.org/10.1016/j.carbpol.2018
.08.020.
44. De Leoz ML, Gaerlan SC, Strum JS, Dimapasoc LM, Mirmiran M, Tancredi
DJ, Smilowitz JT, Kalanetra KM, Mills DA, German JB, Lebrilla CB, Under-
wood MA. 2012. Lacto-N-tetraose, fucosylation, and secretor status
are highly variable in human milk oligosaccharides from women deliv-
ering preterm. J Proteome Res 11:4662–4672. https://doi.org/10.1021/
pr3004979.
45. Lis-Kuberka J, Ka˛tnik-Prastowska I, Berghausen-Mazur M, Orczyk-
Pawiłowicz M. 2015. Lectin-based analysis of fucosylated glycoproteins
of human skim milk during 47 days of lactation. Glycoconj J 32:665–674.
https://doi.org/10.1007/s10719-015-9615-5.
46. Crociani F, Alessandrini A, Mucci MM, Biavati B. 1994. Degradation of
March/April 2019 Volume 10 Issue 2 e00128-19
mbio.asm.org 18

®
Core Fucosylation of Milk N-Glycan Evokes B Cell
complex carbohydrates by Bifidobacterium spp. Int J Food Microbiol
24:199–210. https://doi.org/10.1016/0168-1605(94)90119-8.
47. Peterson R, Cheah WY, Grinyer J, Packer N. 2013. Glycoconjugates in
human milk: protecting infants from disease. Glycobiology 23:
1425–1438. https://doi.org/10.1093/glycob/cwt072.
48. Wu G, Zhang C, Wu H, Wang R, Shen J, Wang L, Zhao Y, Pang X, Zhang
X, Zhao L, Zhang M. 2017. Genomic microdiversity of Bifidobacterium
pseudocatenulatum underlying differential strain-level responses to di-
etary carbohydrate intervention. mBio 8:e02348-16. https://doi.org/10
.1128/mBio.02348-16.
49. Delcaru C, Alexandru I, Podgoreanu P, Cristea VC, Bleotu C, Chifiriuc MC,
Bezirtzoglou E, Lazar V. 2016. Antagonistic activities of some Bifidobac-
terium sp. strains isolated from resident infant gastrointestinal microbi-
ota on Gram-negative enteric pathogens. Anaerobe 39:39–44. https://
doi.org/10.1016/j.anaerobe.2016.02.010.
50. Sanchis-Chorda J, Del Pulgar EMG, Carrasco-Luna J, Benitez-Paez A, Sanz
Y, Codoner-Franch P. 2018. Bifidobacterium pseudocatenulatum CECT
7765 supplementation improves inflammatory status in insulin-resistant
obese children. Eur J Nutr https://doi.org/10.1007/s00394-018-1828-5.
51. Panwar H, Calderwood D, Grant IR, Grover S, Green BD. 2014. Lactoba-
cillus strains isolated from infant faeces possess potent inhibitory activity
against intestinal alpha- and beta-glucosidases suggesting anti-diabetic
potential. Eur J Nutr 53:1465–1474. https://doi.org/10.1007/s00394-013
-0649-9.
52. Rubio R, Jofre A, Martin B, Aymerich T, Garriga M. 2014. Characterization
of lactic acid bacteria isolated from infant faeces as potential probiotic
starter cultures for fermented sausages. Food Microbiol 38:303–311.
https://doi.org/10.1016/j.fm.2013.07.015.
53. Bidart GN, Rodríguez-Díaz J, Yebra MJ. 2016. The extracellular wall-
bound beta-N-acetylglucosaminidase from Lactobacillus casei is in-
volved in the metabolism of the human milk oligosaccharide lacto-N-
triose. Appl Environ Microbiol 82:570–577. https://doi.org/10.1128/AEM
.02888-15.
54. Bidart GN, Rodriguez-Diaz J, Monedero V, Yebra MJ. 2014. A unique gene
cluster for the utilization of the mucosal and human milk-associated
glycans galacto-N-biose and lacto-N-biose in Lactobacillus casei. Mol
Microbiol 93:521–538. https://doi.org/10.1111/mmi.12678.
55. Agustina R, Bovee-Oudenhoven IM, Lukito W, Fahmida U, van de Rest O,
Zimmermann MB, Firmansyah A, Wulanti R, Albers R, van den Heuvel EG,
Kok FJ. 2013. Probiotics Lactobacillus reuteri DSM 17938 and Lactoba-
cillus casei CRL 431 modestly increase growth, but not iron and zinc
status, among Indonesian children aged 1–6 years. J Nutr 143:
1184–1193. https://doi.org/10.3945/jn.112.166397.
63. Rajilic-Stojanovic M, Smidt H, de Vos WM. 2007. Diversity of the human
gastrointestinal tract microbiota revisited. Environ Microbiol 9:2125–2136.
https://doi.org/10.1111/j.1462-2920.2007.01369.x.
64. Tun MH, Tun HM, Mahoney JJ, Konya TB, Guttman DS, Becker AB,
Mandhane PJ, Turvey SE, Subbarao P, Sears MR, Brook JR, Lou W, Takaro
TK, Scott JA, Kozyrskyj AL, CHILD Study Investigators. 2018. Postnatal
exposure to household disinfectants, infant gut microbiota and subse-
quent risk of overweight in children. CMAJ 190:E1097–E1107. https://
doi.org/10.1503/cmaj.170809.
65. Zhao L, Zhang Q, Ma W, Tian F, Shen H, Zhou M. 2017. A combination of
quercetin and resveratrol reduces obesity in high-fat diet-fed rats by
modulation of gut microbiota. Food Funct 8:4644–4656. https://doi.org/
10.1039/c7fo01383c.
66. Derrien M, Vaughan EE, Plugge CM, de Vos WM. 2004. Akkermansia
muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading
bacterium. Int J Syst Evol Microbiol 54:1469–1476. https://doi.org/10
.1099/ijs.0.02873-0.
67. Aakko J, Kumar H, Rautava S, Wise A, Autran C, Bode L, Isolauri E,
Salminen S. 2017. Human milk oligosaccharide categories define the
microbiota composition in human colostrum. Benef Microbes 8:563–567.
https://doi.org/10.3920/BM2016.0185.
68. Zheng H, Liang H, Wang Y, Miao M, Shi T, Yang F, Liu E, Yuan W, Ji ZS,
Li DK. 2016. Altered gut microbiota composition associated with eczema
in infants. PLoS One 11:e0166026. https://doi.org/10.1371/journal.pone
.0166026.
69. Barr PM, Wei C, Roger J, Schaefer-Cutillo J, Kelly JL, Rosenberg AF, Jung
J, Sanz I, Friedberg JW. 2012. Syk inhibition with fostamatinib leads to
transitional B lymphocyte depletion. Clin Immunol 142:237–242. https://
doi.org/10.1016/j.clim.2011.12.012.
70. Liu B, Newburg DS. 2013. Human milk glycoproteins protect infants
against human pathogens. Breastfeed Med 8:354–362. https://doi.org/
10.1089/bfm.2013.0016.
71. Moran AP, Gupta A, Joshi L. 2011. Sweet-talk: role of host glycosylation
in bacterial pathogenesis of the gastrointestinal tract. Gut 60:1412–1425.
https://doi.org/10.1136/gut.2010.212704.
72. Roy R, Baek MG. 2002. Glycodendrimers: novel glycotope isosteres un-
masking sugar coding. Case study with T-antigen markers from breast
cancer MUC1 glycoprotein. J Biotechnol 90:291–309.
73. Bidart GN, Rodríguez-Díaz J, Palomino-Schätzlein M, Monedero V, Yebra
MJ. 2017. Human milk and mucosal lacto- and galacto-N-biose synthesis
by transgalactosylation and their prebiotic potential in Lactobacillus
species. Appl Microbiol Biotechnol 101:205–215. https://doi.org/10
.1007/s00253-016-7882-0.
56. Shokryazdan P, Sieo CC, Kalavathy R, Liang JB, Alitheen NB, Faseleh
Jahromi M, Ho YW. 2014. Probiotic potential of Lactobacillus strains with
antimicrobial activity against some human pathogenic strains. Biomed
Res Int 2014:927268. https://doi.org/10.1155/2014/927268.
74. Rodriguez-Diaz J, Monedero V, Yebra MJ. 2011. Utilization of natural
fucosylated oligosaccharides by three novel ␣-L-fucosidases from a pro-
biotic Lactobacillus casei strain. Appl Environ Microbiol 77:703–705.
https://doi.org/10.1128/AEM.01906-10.
57. Boonma P, Spinler JK, Venable SF, Versalovic J, Tumwasorn S. 2014.
Lactobacillus rhamnosus L34 and Lactobacillus casei L39 suppress Clos-
tridium difficile-induced IL-8 production by colonic epithelial cells. BMC
Microbiol 14:177. https://doi.org/10.1186/1471-2180-14-177.
58. Watanabe M, Kinoshita H, Nitta M, Yukishita R, Kawai Y, Kimura K,
Taketomo N, Yamazaki Y, Tateno Y, Miura K, Horii A, Kitazawa H, Saito T.
2010. Identification of a new adhesin-like protein from Lactobacillus
mucosae ME-340 with specific affinity to the human blood group A and
B antigens. J Appl Microbiol 109:927–935. https://doi.org/10.1111/j.1365
-2672.2010.04719.x.
59. Hsieh MH, Jan RL, Wu LS, Chen PC, Kao HF, Kuo WS, Wang JY. 2018.
Lactobacillus gasseri attenuates allergic airway inflammation through
PPARgamma activation in dendritic cells. J Mol Med (Berl) 96:39–51.
https://doi.org/10.1007/s00109-017-1598-1.
60. Underwood MA, Sohn K. 2017. The microbiota of the extremely preterm
infant. Clin Perinatol 44:407–427. https://doi.org/10.1016/j.clp.2017.01
.005.
61. Richards MJ, Edwards JR, Culver DH, Gaynes RP. 2000. Nosocomial
infections in combined medical-surgical intensive care units in the
United States. Infect Control Hosp Epidemiol 21:510–515. https://doi
.org/10.1086/501795.
62. Ma B, McComb E, Gajer P, Yang H, Humphrys M, Okogbule-Wonodi AC,
Fasano A, Ravel J, Viscardi RM. 2018. Microbial biomarkers of intestinal
barrier maturation in preterm infants. Front Microbiol 9:2755. https://doi
.org/10.3389/fmicb.2018.02755.
75. Tsai TI, Li ST, Liu CP, Chen KY, Shivatare SS, Lin CW, Liao SF, Lin CW, Hsu
TL, Wu YT, Tsai MH, Lai MY, Lin NH, Wu CY, Wong CH. 2017. An effective
bacterial fucosidase for glycoprotein remodeling. ACS Chem Biol 12:
63–72. https://doi.org/10.1021/acschembio.6b00821.
76. Hill CJ, Lynch DB, Murphy K, Ulaszewska M, Jeffery IB, O’Shea CA, Watkins
C, Dempsey E, Mattivi F, Tuohy K, Ross RP, Ryan CA, O’Toole PW, Stanton
C. 2017. Evolution of gut microbiota composition from birth to 24 weeks
in the INFANTMET Cohort. Microbiome 5:4. https://doi.org/10.1186/
s40168-016-0213-y.
77. Wang C, Wu Z, Yuan J, Wang B, Zhang P, Zhang Y, Wang Z, Huang L.
2014. Simplified quantitative glycomics using the stable isotope label
Girard’s reagent P by electrospray ionization mass spectrometry. J Pro-
teome Res 13:372–384. https://doi.org/10.1021/pr4010647.
78. Chai W, Piskarev V, Lawson AM. 2001. Negative-ion electrospray mass
spectrometry of neutral underivatized oligosaccharides. Anal Chem 73:
651–657. https://doi.org/10.1021/ac0010126.
79. Li J, Zhao F, Wang Y, Chen J, Tao J, Tian G, Wu S, Liu W, Cui Q, Geng B, Zhang
W, Weldon R, Auguste K, Yang L, Liu X, Chen L, Yang X, Zhu B, Cai J. 2017.
Gut microbiota dysbiosis contributes to the development of hypertension.
Microbiome 5:14. https://doi.org/10.1186/s40168-016-0222-x.
80. National Research Council. 2011. Guide for the care and use of labora-
tory animals, 8th ed. National Academies Press, Washington, DC.
81. Wang SH, Yu J. 2016. Data for peptide-binding assay with oriented
immobilization of GRP78 in Biacore. Data Brief 7:1696–1699. https://doi
.org/10.1016/j.dib.2016.04.064.
March/April 2019 Volume 10 Issue 2 e00128-19
mbio.asm.org 19